ici 204,219 has been researched along with Cancer of Ovary in 1 studies
zafirlukast: a leukotriene D4 receptor antagonist
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gelzinis, JA | 1 |
| Szahaj, MK | 1 |
| Bekendam, RH | 1 |
| Wurl, SE | 1 |
| Pantos, MM | 1 |
| Verbetsky, CA | 1 |
| Dufresne, A | 1 |
| Shea, M | 1 |
| Howard, KC | 1 |
| Tsodikov, OV | 1 |
| Garneau-Tsodikova, S | 1 |
| Zwicker, JI | 1 |
| Kennedy, DR | 1 |
1 other study available for ici 204,219 and Cancer of Ovary
| Article | Year |
|---|---|
Targeting thiol isomerase activity with zafirlukast to treat ovarian cancer from the bench to clinic.
Topics: Animals; Blood Platelets; Female; Humans; Indoles; Mice; Ovarian Neoplasms; Phenylcarbamates; Sulfhy | 2023 |